About Pragya Pandey
Pragya is an equity research analyst and financial journalist with a passion for investing. In college she majored in finance and is currently pursuing the CFA program and is a Level II candidate.
When analyzing stocks, Pragya takes a fundamental approach and focuses on measuring a company's intrinsic value. Her goal is to help retail investors create successful portfolios to achieve financial success.
Recent Articles By Pragya Pandey
Up 58% in 2021, is Accenture Stock Still a Good Buy?
Renowned professional services company Accenture (ACN) has recovered significantly from its pandemic lows thanks to its broad market reach and strategic partnerships. Although ACN’s shares gained more than 58% in price last year, considering the continuing rapid digitalization globally, is it worth owning the stock now? Let's discuss.
Down More Than 80% in 2021, is Now a Good Time to Buy Shares of Root?
Root (ROOT) is a popular auto-insurance company that made its stock market debut in October 2020. Though the company is continuously improving its underwriting capabilities and fine-tuning its operating efficiency, the stock has plummeted more than 80% in price over the past year. So, given ROOT’s widening losses and negative profit margins, can its shares recover in the near term? Let's find out. Read on.
Down More Than 85% in 2021, is Now a Good Time to Scoop Up XL Fleet?
A hybrid electric solutions provider for the commercial and public EV market, the shares of XL Fleet (XL) have lost momentum amid current uncertainties related to the EV industry. So, the question is, is it worth adding the stock to one’s portfolio now? Read on to learn more.
Currently Trading Near All-Time Highs, is McDonald's Still a Buy?
Global fast-food chain operator McDonald's (MCD) delivered strong operating performance across all segments in its last reported quarter. Furthermore, its stock possesses solid growth attributes. So, although MCD is currently hovering near its all-time price high, is it worth betting on the stock now, given its aforementioned positives? Read on.
2 Beaten-Down Medical Device Stocks to Buy for a 2022 Rebound
The medical devices industry witnessed a solid recovery last year. And this trend will likely continue, driven by rising demand for non-emergency medical procedures and rapid tech integration. Thus, we think buying the dip in quality medical devices stocks Medtronic (MDT) and Zimmer Biomet (ZBH) could deliver handsome returns this year. Read on.
Is SOS Limited Stock a Buy Under $1?
Shares of China-based emerging blockchain company SOS limited (SOS) have plunged 82.5% over the past nine months due to China's regulatory crackdown on tech firms. In addition, the company's recent private placement to fund its growth did not bode well. So, would it be worth adding the stock to your portfolio at the current price level? Read on to learn more.
2 Hydrogen Stocks Wall Street Is Bullish on for 2022
An increasing focus on clean energy to address climate change concerns, coupled with growing government regulations to control toxic emissions from fuels, is expected to propel the growth of the hydrogen industry. Therefore, Wall Street analysts expect hydrogen stocks Plug Power (PLUG) and Ballard Power Systems (BLDP) to generate significant returns in the coming months. So, read on to learn more.
2 Utility Stocks to Avoid, According to Wall Street
The defensive sectors, including Utilities, have witnessed significant investor attention over the past few weeks due to concerns over the continued spread of the omicron variant and rising prices. However, some analysts believe the price surge may be short-lived as investors could return to the large technology and growth firms that have driven the markets for years. Therefore, utility stocks Consolidated Edison (ED) and ALLETE (ALE) are best avoided now. Wall Street analysts expect them to witness a price decline in the coming months.
Is Digital Turbine a Good Software Stock to Own in 2022?
Digital Turbine (APPS) has witnessed a tremendous transition from a penny stock to a billion-dollar company over the past three years, registering solid gains along the way. However, the stock is currently trading at a premium to its peers. Moreover, given its weak fundamentals, is it worth investing in the stock now?